OR WAIT null SECS
October 11, 2019
The collaboration aims to reduce “vein-to-vein” time for patients and to optimize manufacturing and supply operations.
October 10, 2019
CPI, the University of Strathclyde, GSK, and AstraZeneca Collaborate on a continuous direct compression digital twin for pharmaceutical formulation optimization.
MilliporeSigma will now be the first company to make acoustic technology available for cell therapy manufacturing.
October 08, 2019
The new facility raises production capacity by an additional 19,100 m2 and creates 200 new full-time jobs.
The collaboration focuses on baculovirus/Sf9 expression system for Prevail's pipeline of novel AAV9-based gene therapy programs neurodegenerative diseases.
October 04, 2019
GSK invested $139 million to its Rockville, MD site to support demand for Benlysta.
The new joint venture, named Oerth Bio, will use Arvinas’ Protac technology to develop innovative new agricultural products. As part of its collaboration with Arvinas, Bayer is also using this technology to develop human therapeutics.
October 02, 2019
The root cause of NDMA contamination may go well beyond manufacturing problems, to the molecule itself.
The new incubators are set to be operational starting in 2021.
October 01, 2019
AstraZeneca has received a complete response letter from FDA regarding its new drug application for a budesonide/glycopyrronium/formoterol fumarate triple-combination therapy for treating chronic obstructive pulmonary disease.